Gagnon Robert E.
- SEC CIK
- 0001504983
In the past year, 4 open-market sale filings worth $193.4K and no purchases.
Current role at each company
- IRD Opus Genetics, Inc.Chief Financial Officeras of Sep 8, 2026
- HBIO Harvard Bioscience IncDirectoras of Jun 11, 2026
- VSTM Verastem, Inc.Directoras of Dec 18, 2025
- BBLG Bone Biologics CorpDirectoras of Jun 6, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $193.4K
- 4 filings
- Net
- −$193.4K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Gagnon Robert E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IRD Opus Genetics, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 (view filing)4:05 PM ET | Sep 3 | 5 days | Gagnon Robert E.Chief Financial Officer | SSale | −28.0K | $4.54 | −$127.2K | −4.8%556.4K after | |
| Jul 27, 2026 (view filing)4:06 PM ET | Jul 23 | 4 days | Gagnon Robert E.Chief Financial Officer | SSale | −7.78K | $2.95 | −$22.9K | −1.3%584.4K after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Gagnon Robert E.Chief Financial Officer | SSale | −7.84K | $5.18 | −$40.6K | −1.3%592.2K after |
VSTM Verastem, Inc.
Director22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing) | Dec 16 | 2 days | Gagnon Robert E.Director | SSale | −283 | $9.14 | −$2.59K | −0.7%41.7K after | 10b5-1 |
| Sep 18, 2025 (view filing) | Sep 16 | 2 days | Gagnon Robert E.Director | SSale | −281 | $9.99 | −$2.81K | −0.7%42.0K after | 10b5-1 |
| Jun 20, 2025 (view filing) | Jun 16 | 4 daysLate | Gagnon Robert E.Director | SSale | −284 | $5.65 | −$1.60K | −0.7%42.2K after | |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Gagnon Robert E.Director | SSale | −284 | $6.95 | −$1.97K | −0.8%34.2K after | |
| Dec 20, 2024 (view filing) | Dec 16-19 | 4 daysLate | Gagnon Robert E.Director | SSale | −415 | $4.49 | −$1.86K | −1.2%34.5K after | 2 lots |
| Sep 20, 2024 (view filing) | Sep 19 | 1 day | Gagnon Robert E.Director | SSale | −131 | $2.79 | −$365.49 | −0.4%34.9K after | |
| Sep 18, 2024 (view filing) | Sep 16 | 2 days | Gagnon Robert E.Director | SSale | −287 | $2.80 | −$803.6 | −0.8%35.0K after | |
| Jun 20, 2024 (view filing) | Jun 17-20 | 3 days | Gagnon Robert E.Director | SSale | −414 | $3.40 | −$1.41K | −1.2%35.3K after | 2 lots |
| Mar 20, 2024 (view filing) | Mar 18-19 | 2 days | Gagnon Robert E.Director | SSale | −413 | $10.61 | −$4.38K | −1.5%27.4K after | 2 lots |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Gagnon Robert E.Director | SSale | −9.20K | $13.70 | −$126.1K | −24.9%27.8K after | 10b5-1 |